Hong Kong could be first to get Swiss start-up’s drug for diabetic eye disease

By Eric Ng

Oculis’ OCS-01 eye drops, currently in phase 3 trials for diabetic macular edema, can be an alternative to injection, CEO says.

Source: South China Morning Post